Clinical Trial Update: Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating LVGN3616 and LVGN6051±LVGN7409 with nab-paclitaxel or bevacizumab and cyclophosphamide in various metastatic solid tumors; study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer
• Head and Neck Cancer
• Hepatocellular Carcinoma
• Human Papillomavirus-related Cancers
• Ovarian Cancer
• Soft Tissue Sarcoma
• Uveal Melanoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Avastin (bevacizumab)
• Cytoxan (cyclophosphamide)
• LVGN3616
• LVGN6051
• LVGN7409

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Esophageal, Gastric Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING